Skip to main content
Erschienen in: Intensive Care Medicine 1/2021

06.11.2020 | COVID-19 | Letter Zur Zeit gratis

Impact of late administration of corticosteroids in COVID-19 ARDS

verfasst von: Nicolas Mongardon, Michael Piagnerelli, David Grimaldi, Bastien Perrot, Jean-Baptiste Lascarrou, COVADIS study group investigators

Erschienen in: Intensive Care Medicine | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (2020) Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa2021436CrossRef RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (2020) Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med. https://​doi.​org/​10.​1056/​NEJMoa2021436CrossRef
2.
Zurück zum Zitat WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JPT, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini B, Veiga VC, Webb S, Marshall JC (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 324(13):1330–1341. https://doi.org/10.1001/jama.2020.17023CrossRef WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JPT, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini B, Veiga VC, Webb S, Marshall JC (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 324(13):1330–1341. https://​doi.​org/​10.​1001/​jama.​2020.​17023CrossRef
3.
Zurück zum Zitat Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684CrossRef Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684CrossRef
4.
Zurück zum Zitat Grimaldi D, Aissaoui N, Blonz G, Carbutti G, Courcelle R, Gaudry S, Gaultier A, D’Hondt A, Higny J, Horlait G, Hraiech S, Lefebvre L, Lejeune F, Ly A, Piagnerelli M, Sauneuf B, Serck N, Soumagne T, Szychowiak P, Textoris J, Vandenbunder B, Vinsonneau C, Lascarrou JB, Group Cs (2020) Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study. Ann Intensive Care 10:131CrossRef Grimaldi D, Aissaoui N, Blonz G, Carbutti G, Courcelle R, Gaudry S, Gaultier A, D’Hondt A, Higny J, Horlait G, Hraiech S, Lefebvre L, Lejeune F, Ly A, Piagnerelli M, Sauneuf B, Serck N, Soumagne T, Szychowiak P, Textoris J, Vandenbunder B, Vinsonneau C, Lascarrou JB, Group Cs (2020) Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study. Ann Intensive Care 10:131CrossRef
Metadaten
Titel
Impact of late administration of corticosteroids in COVID-19 ARDS
verfasst von
Nicolas Mongardon
Michael Piagnerelli
David Grimaldi
Bastien Perrot
Jean-Baptiste Lascarrou
COVADIS study group investigators
Publikationsdatum
06.11.2020
Verlag
Springer Berlin Heidelberg
Schlagwort
COVID-19
Erschienen in
Intensive Care Medicine / Ausgabe 1/2021
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-020-06311-z

Weitere Artikel der Ausgabe 1/2021

Intensive Care Medicine 1/2021 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.